Analytical Data
-
Gene name
DNP
- Application
-
Species
Dendroaspis angusticeps
-
Source
E. coli
-
Tag
N- His-KSI
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P28374
-
Expression Region
1-38aa
-
Molecular Weight
19.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DNP recombinant proteins have garnered significant attention in the fields of biotechnology and medicine due to their role in understanding and manipulating cellular processes. DNP, or dinitrophenol, is a chemical compound that disrupts cellular energy production, leading to increased metabolic rates. The production of DNP recombinant proteins involves genetic engineering techniques to express specific proteins associated with various biological functions and pathways. Researchers aim to explore the therapeutic potential of these proteins, particularly in cancer research, metabolic disorders, and bioengineering applications. By studying DNP recombinant proteins, scientists can gain insights into protein interactions, signaling pathways, and cellular responses to stress, ultimately paving the way for innovative treatments and biotechnological advancements. The synthesis and characterization of these proteins facilitate a deeper understanding of their mechanisms of action, enabling the development of targeted therapies that could improve patient outcomes. As the demand for novel therapeutic strategies grows, DNP recombinant proteins represent a promising avenue for future research, offering potential solutions to pressing health challenges.
